• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小胶质细胞代谢重编程通过 EphA2/p38MAPK 通路增强阿尔茨海默病中的促炎细胞因子释放。

Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.

机构信息

Department of Anatomy, Hebei Medical University, Shijiazhuang, P.R. China.

Neuroscience Research Center, Hebei Medical University, Shijiazhuang, P.R. China.

出版信息

J Alzheimers Dis. 2022;88(2):771-785. doi: 10.3233/JAD-220227.

DOI:10.3233/JAD-220227
PMID:35694923
Abstract

BACKGROUND

The activation of microglia and neuroinflammation has been implicated in the pathogenesis of Alzheimer's disease (AD), but the exact roles of microglia and the underlying mechanisms remain unclear.

OBJECTIVE

To clarify how the metabolic reprogramming of microglia induce by amyloid-β (Aβ)1-42 to affect the release of proinflammatory cytokines in AD.

METHODS

MTS assay was used to detect the viability of BV2 cells treated with different concentrations of Aβ1-42 for different periods of time. The expression levels of proinflammatory cytokines were determined by qRT-PCR and western blot assay in BV2 cells and hippocampus of mice. RNA sequencing was applied to evaluate the gene expression profiles in response to HK2 knockdown in BV2 cells treated with Aβ1-42.

RESULTS

Low concentrations of Aβ1-42 increased the viability of BV2 cells and promoted the release of proinflammatory cytokines, and this process is accompanied by increased glycolysis. Inhibition of glycolysis significantly downregulated the release of proinflammatory cytokines in BV2 cells and hippocampus of mice treated with Aβ1-42. The results of RNA sequencing revealed the expression of chemokine ligand 2 (Cxcl2) and ephrin receptor tyrosine kinase A2 (EphA2) were significantly downregulated when knocked down HK2 in BV2 cells. Subsequently, the expression of proinflammatory cytokines was downregulated in BV2 cell after knocking down EphA2.

CONCLUSION

This study demonstrated that EphA2/p38 MAPK pathway is involved the release of proinflammatory cytokines in microglia induced by Aβ1-42 in AD, which is accompanied by metabolic reprogramming from oxidative phosphorylation (OXPHOS) to glycolysis.

摘要

背景

小胶质细胞的激活和神经炎症与阿尔茨海默病(AD)的发病机制有关,但小胶质细胞的确切作用和潜在机制仍不清楚。

目的

阐明淀粉样蛋白β(Aβ)1-42 诱导的小胶质细胞代谢重编程如何影响 AD 中小胶质细胞促炎细胞因子的释放。

方法

用 MTS 法检测不同浓度 Aβ1-42 作用不同时间对 BV2 细胞活力的影响。qRT-PCR 和 Western blot 检测 BV2 细胞和小鼠海马中促炎细胞因子的表达水平。应用 RNA 测序评估 HK2 敲低后 Aβ1-42 处理的 BV2 细胞中的基因表达谱。

结果

低浓度 Aβ1-42 增加了 BV2 细胞的活力并促进了促炎细胞因子的释放,这一过程伴随着糖酵解的增加。抑制糖酵解显著下调了 Aβ1-42 处理的 BV2 细胞和小鼠海马中促炎细胞因子的释放。RNA 测序结果显示,HK2 敲低后 BV2 细胞中趋化因子配体 2(Cxcl2)和 Eph 受体酪氨酸激酶 A2(EphA2)的表达明显下调。随后,EphA2 敲低后,BV2 细胞中的促炎细胞因子表达下调。

结论

本研究表明,EphA2/p38 MAPK 通路参与了 Aβ1-42 诱导的 AD 中小胶质细胞促炎细胞因子的释放,伴随着从氧化磷酸化(OXPHOS)到糖酵解的代谢重编程。

相似文献

1
Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.小胶质细胞代谢重编程通过 EphA2/p38MAPK 通路增强阿尔茨海默病中的促炎细胞因子释放。
J Alzheimers Dis. 2022;88(2):771-785. doi: 10.3233/JAD-220227.
2
Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis.阿尔茨海默病中 miR-181c-5p 的下调削弱了小胶质细胞对 Aβ 吞噬的反应。
Sci Rep. 2024 May 20;14(1):11487. doi: 10.1038/s41598-024-62347-x.
3
Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway.脂联素通过 AdipoR1-AMPK-NF-κB 信号通路抑制小胶质细胞中淀粉样β寡聚体 (AβO) 诱导的炎症反应。
J Neuroinflammation. 2019 May 25;16(1):110. doi: 10.1186/s12974-019-1492-6.
4
Aβ promotes CD38 expression in senescent microglia in Alzheimer's disease.Aβ 在阿尔茨海默病中促进衰老小胶质细胞中 CD38 的表达。
Biol Res. 2022 Mar 3;55(1):10. doi: 10.1186/s40659-022-00379-1.
5
LRP1 knockdown aggravates Aβ-stimulated microglial and astrocytic neuroinflammatory responses by modulating TLR4/NF-κB/MAPKs signaling pathways.LRP1 knockdown 通过调节 TLR4/NF-κB/MAPKs 信号通路加重 Aβ 刺激的小胶质细胞和星形胶质细胞神经炎症反应。
Exp Cell Res. 2020 Sep 15;394(2):112166. doi: 10.1016/j.yexcr.2020.112166. Epub 2020 Jul 6.
6
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.抗疟药青蒿琥酯通过 Nrf2 依赖性机制抑制 BV2 小胶质细胞中的神经炎症。
Mol Neurobiol. 2016 Nov;53(9):6426-6443. doi: 10.1007/s12035-015-9543-1. Epub 2015 Nov 25.
7
The p38 mitogen-activated protein kinase signaling pathway is involved in regulating low-density lipoprotein receptor-related protein 1-mediated β-amyloid protein internalization in mouse brain.p38丝裂原活化蛋白激酶信号通路参与调节小鼠脑中低密度脂蛋白受体相关蛋白1介导的β-淀粉样蛋白内化。
Int J Biochem Cell Biol. 2016 Jul;76:75-86. doi: 10.1016/j.biocel.2016.04.019. Epub 2016 May 6.
8
p38 MAPK Is a Major Regulator of Amyloid Beta-Induced IL-6 Expression in Human Microglia.p38 MAPK 是人类小神经胶质细胞中淀粉样β诱导的 IL-6 表达的主要调节因子。
Mol Neurobiol. 2022 Sep;59(9):5284-5298. doi: 10.1007/s12035-022-02909-0. Epub 2022 Jun 13.
9
Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.小胶质细胞淀粉样蛋白受体在介导β淀粉样蛋白(Aβ)诱导的炎症中的作用。
J Neuroinflammation. 2017 Oct 6;14(1):199. doi: 10.1186/s12974-017-0972-9.
10
A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.代谢重编程的崩溃导致阿尔茨海默病中小胶质细胞功能障碍。
Cell Metab. 2019 Sep 3;30(3):493-507.e6. doi: 10.1016/j.cmet.2019.06.005. Epub 2019 Jun 27.

引用本文的文献

1
Systems pharmacology identifies ajugol-mediated NF-κB/caspase-3 inhibition and isoacteoside-driven p62/mTOR-mediated autophagy as key mechanisms of Rehmanniae Radix and its processed form in Alzheimer's treatment.系统药理学确定了紫丁香苷介导的NF-κB/半胱天冬酶-3抑制以及异毛蕊花糖苷驱动的p62/雷帕霉素靶蛋白介导的自噬,作为生地黄及其炮制品在治疗阿尔茨海默病中的关键机制。
Front Pharmacol. 2025 Aug 29;16:1644847. doi: 10.3389/fphar.2025.1644847. eCollection 2025.
2
Expression of CD44 and Its Spliced Variants: Innate and Inducible Roles in Nervous Tissue Cells and Their Environment.CD44及其剪接变体的表达:在神经组织细胞及其环境中的固有和诱导作用
Int J Mol Sci. 2025 Aug 24;26(17):8223. doi: 10.3390/ijms26178223.
3
Metabolic Profiling Reveals a Glycolytic Shift and an IRG1/Itaconate/NF2L2 Axis Regulating Neurotoxic Oxidative Stress in Inflammatory Microglia.
代谢谱分析揭示了炎症性小胶质细胞中糖酵解转变以及调节神经毒性氧化应激的IRG1/衣康酸/NF2L2轴。
J Neurochem. 2025 Sep;169(9):e70219. doi: 10.1111/jnc.70219.
4
Inhibition of 12/15-LOX hyperactivation mitigates cognitive decline in a chronic cerebral hypoperfusion mouse model and in HO-induced HT22 cells: therapeutic effects of brozopine.抑制12/15-脂氧合酶过度激活可减轻慢性脑灌注不足小鼠模型和HO诱导的HT22细胞中的认知衰退:溴佐平的治疗作用
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2547259. doi: 10.1080/14756366.2025.2547259. Epub 2025 Aug 21.
5
tRF attenuates neuroinflammation and neuronal damage in Alzheimer's disease via the EphA7-ERK-p70S6K signaling pathway.tRF通过EphA7-ERK-p70S6K信号通路减轻阿尔茨海默病中的神经炎症和神经元损伤。
Alzheimers Res Ther. 2025 May 15;17(1):104. doi: 10.1186/s13195-025-01734-6.
6
Natural polyphenol mangiferin delays neuronal cell senescence by inhibiting neuroinflammation mediated by microglial activation.天然多酚芒果苷通过抑制小胶质细胞激活介导的神经炎症来延缓神经元细胞衰老。
IBRO Neurosci Rep. 2025 Apr 8;18:574-591. doi: 10.1016/j.ibneur.2025.04.006. eCollection 2025 Jun.
7
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research.解读小胶质细胞免疫代谢:阿尔茨海默病研究的新前沿
Mol Neurodegener. 2025 Mar 27;20(1):37. doi: 10.1186/s13024-025-00825-0.
8
Glycolytic dysregulation in Alzheimer's disease: unveiling new avenues for understanding pathogenesis and improving therapy.阿尔茨海默病中的糖酵解失调:揭示理解发病机制和改善治疗的新途径。
Neural Regen Res. 2025 Aug 1;20(8):2264-2278. doi: 10.4103/NRR.NRR-D-24-00190. Epub 2024 Jul 29.
9
AITeQ: a machine learning framework for Alzheimer's prediction using a distinctive five-gene signature.AITeQ:使用独特的五基因特征进行阿尔茨海默病预测的机器学习框架。
Brief Bioinform. 2024 May 23;25(4). doi: 10.1093/bib/bbae291.
10
Interactions between genes involved in physiological dysregulation and axon guidance: role in Alzheimer's disease.参与生理调节异常的基因与轴突导向之间的相互作用:在阿尔茨海默病中的作用。
Front Genet. 2023 Aug 31;14:1236509. doi: 10.3389/fgene.2023.1236509. eCollection 2023.